Neuro-Ophthalmic Manifestations of Sarcoidosis: Clinical Spectrum, Evaluation, and Management

Objective To familiarize the reader with the neuro-ophthalmic manifestations of sarcoidosis. Materials and Methods All patients underwent systemic evaluations (chest radiograph, magnetic resonance imaging and/or computed tomography, serum angiotensin-converting enzyme level, and gallium scan). Histologic confirmation was preferred (11 of 15 patients underwent biopsy, ten of whom [82%] had positive biopsies, and four refused). Otherwise, the diagnosis of clinical sarcoidosis was based on laboratory evaluation. Results We report our experience with 15 patients who had neuro-ophthalmic manifestations of sarcoidosis other than optic neuropathy or chiasmal disease. Eight of 15 (53%) did not have known sarcoidosis at the time of presentation. Thirteen of 15 (87%) patients demonstrated lesions consistent with sarcoidosis on magnetic resonance imaging of the brain. Treatment with corticosteroids and/or other immunomodulatory agents was necessary in all cases. Conclusions Neuro-ophthalmic manifestations of sarcoidosis are rare. They may be the presenting signs of otherwise occult disease. Suspicion and inclusion in the differential are a key to establishing the diagnosis. A strategy for the detection and evaluation of these cases is presented.

[1]  M. Meziane,et al.  Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. , 1998, American journal of ophthalmology.

[2]  P. Lama,et al.  Annual Review of Systemic Disease‐1997-II , 1998, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[3]  D. Valeyre,et al.  Sarcoïdose du système nerveux central , 1998 .

[4]  J. Broderick,et al.  Diagnosis and management of neurological sarcoidosis. , 1997, Archives of internal medicine.

[5]  D. James Differential diagnosis of facial nerve palsy. , 1997, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[6]  B. Stern,et al.  Therapeutic considerations in patients with refractory neurosarcoidosis. , 1995, Archives of neurology.

[7]  R. Grossman,et al.  MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. , 1994, AJNR. American journal of neuroradiology.

[8]  Sharma Op,et al.  Role of magnetic resonance imaging in neurosarcoidosis. , 1993 .

[9]  L. Bielory,et al.  Low-dose cyclosporine therapy of granulomatous optic neuropathy and orbitopathy. , 1991, Ophthalmology.

[10]  D. MacManus,et al.  Magnetic resonance imaging in central nervous system sarcoidosis , 1988, Neurology.

[11]  G. Klintworth,et al.  Sarcoidosis and its ophthalmic manifestations. , 1978, American journal of ophthalmology.

[12]  P. Delaney Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. , 1977, Annals of internal medicine.

[13]  G. Schwesinger,et al.  [Sarcoidosis of the central nervous system]. , 1976, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[14]  T. de Brito,et al.  Granulomatous inflammation. , 1994, Revista do Instituto de Medicina Tropical de Sao Paulo.

[15]  J. Kadakia,et al.  Role of magnetic resonance imaging in neurosarcoidosis. , 1993, Sarcoidosis.

[16]  F. Dubas [Neurologic manifestations of sarcoidosis]. , 1988, La Revue de medecine interne.

[17]  W. Bonte,et al.  Evidence for a new allele at the esterase D (E.C.3.1.1.1) locus. , 1988, Human heredity.

[18]  P. D. Thomas,et al.  Current concepts of the pathogenesis of sarcoidosis. , 1987, The American review of respiratory disease.

[19]  B. Strom,et al.  Epidemiology of sarcoidosis. , 1983, Epidemiologic reviews.